Stem Cell And Tissue Engineering Research Private Limited - Company Profile

It is a research & development private limited company based in Bangalore, Karnataka, India, established in 2011.
2011 Bangalore, Karnataka, India Struck Off
Last Updated:
About Stem Cell And Tissue Engineering Research Private Limited

Stem Cell And Tissue Engineering Research Private Limited, a struck off private limited company, was established on 22 November 2011 in Bangalore, Karnataka, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U73100KA2011PTC061274. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.10 M and a paid-up capital of ₹4.07 M.

It upholds a compliant status. Its leadership includes Shama Bhat (Managing Director), Susheela Shama Bhat (Director). Past directors included Manoj Vinoy Mojamdar. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 11- A, 4Th Cross, Veerasandra Industrial Area , Electronic City, Bangalore, Karnataka, 560100.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2011PTC061274

  • Registration Number

    061274

  • Incorporation Date

    22 November 2011

  • Authorized Capital

    ₹4.10 M

  • Paid-Up Capital

    ₹4.07 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 4.10 M
  • Paid Up Capital ₹ 4.07 M
  • Company Age 14 Year, 2 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** %
  • Profit Growth **** 60.72%
  • Ebitda **** 70.38%
  • Net Worth -0.36%
  • Total Assets **** %
Company report

Stem Cell And Tissue Engineering Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stem Cell And Tissue Engineering Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Stem Cell And Tissue Engineering Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Shama Bhat Managing Director 22 Nov 2011 Current
Susheela Shama Bhat Director 22 Nov 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jul 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stem Cell And Tissue Engineering Research.

Stem Cell And Tissue Engineering Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 60.72% increase in profit. The company's net worth dipped by a decrease of 0.36%.

Stem Cell And Tissue Engineering Research revenue growth over time
Stem Cell And Tissue Engineering Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
60.72%
*******
*******
*******
*******
Net Worth
*******
-0.36%
*******
*******
*******
*******
EBITDA
*******
70.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stem Cell And Tissue Engineering Research?

In 2017, Stem Cell And Tissue Engineering Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stem Cell And Tissue Engineering Research?

Unlock and access historical data on people associated with Stem Cell And Tissue Engineering Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stem Cell And Tissue Engineering Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell And Tissue Engineering Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stem Cell And Tissue Engineering Research
Recent Activity within the Organization
  • Annual General Meeting

    Stem Cell And Tissue Engineering Research Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Stem Cell And Tissue Engineering Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Bangalore. was documented.

  • Director Appointment

    The activity Shama Bhat was appointed as a Managing Director was appointed as a Managing Director on 22 Nov 2011 & has been associated with this company since 14 years 2 months . was completed.

  • Director Appointment

    Progress on Susheela Shama Bhat was appointed as a Director was appointed as a Director on 22 Nov 2011 & has been associated with this company since 14 years 2 months . was documented.

  • Company Incorporation

    The activity Stem Cell And Tissue Engineering Research Private Limited was registered on 22 Nov 2011 with Roc Bangalore & aged 14 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stem Cell And Tissue Engineering Research Private Limited?

The CIN of Stem Cell And Tissue Engineering Research Private Limited is U73100KA2011PTC061274.

Where is Stem Cell And Tissue Engineering Research Private Limited headquartered?

Stem Cell And Tissue Engineering Research Private Limited is headquartered at 11- A, 4Th Cross, Veerasandra Industrial Area , Electronic City, Bangalore, Karnataka, 560100.

When was Stem Cell And Tissue Engineering Research Private Limited incorporated?

Stem Cell And Tissue Engineering Research Private Limited was incorporated on 22 November 2011.

Who are the current directors of Stem Cell And Tissue Engineering Research Private Limited?

The current directors of Stem Cell And Tissue Engineering Research Private Limited are

What is the primary industry of Stem Cell And Tissue Engineering Research Private Limited?

The primary industry of Stem Cell And Tissue Engineering Research Private Limited is Professional, Scientific And Technical.

Is Stem Cell And Tissue Engineering Research Private Limited a listed company?

Stem Cell And Tissue Engineering Research Private Limited is unlisted.

What is the capital structure of Stem Cell And Tissue Engineering Research Private Limited?

The authorized capital of Stem Cell And Tissue Engineering Research Private Limited is ₹4.10 M, and the paid-up capital is ₹4.07 M.

What is the compliance status of Stem Cell And Tissue Engineering Research Private Limited?

The compliance status of Stem Cell And Tissue Engineering Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available